I-hui Chen

Dr. I-hui Chen


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
CLChien-Hsing Lu
Chien-Hsing Lu
ICI-hui Chen
I-hui Chen
YCYi-Jen Chen
Yi-Jen Chen
KWKung-Liahng Wang
Kung-Liahng Wang
JQJian-Tai Timothy Qiu
Jian-Tai Timothy Qiu
YHYao-Ching Hung
Yao-Ching Hung

1 April 2016 in Medicine
Verified
Journal Article
Open access
JCJen-Ruei Chen
Jen-Ruei Chen
TCTing-Chang Chang
Ting-Chang Chang
HFHung-Chun Fu
Hung-Chun Fu
HLHei-Yu Lau
Hei-Yu Lau
ICI-hui Chen
I-hui Chen
Peng-Hui WangPeng-Hui Wang
Peng-Hui Wang
In the management of patients with advanced-stage pure endometrioid-type endometrial cancer (E-EC), such as positive lymph nodes (stage III) or stage IV, treatment options are severely limited. This article aims to investigate the outcome of women with FIGO III-IV E-EC (based on FIGO 2009 system). The retrospective cohort study, based on the Taiwanese Gynecologic Oncology Group (TGOG-2005), enrolled patients undergoing staging surgery to have a pathologically confirmed FIGO III-IV E-EC from 22-member hospitals between 1991 and 2010. This cohort included 541 patients (stage III, n = 464; stage IV, n = 77). Five-year overall survival (OS) was 70.4%. Median progression-free survival (PFS) was 43 months (range 0-258 months) and median OS was 52 months (range 1-258 months). Multivariate analysis showed that FIGO stage, >1/2 myometrial invasion (hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.12-2.09; P = 0.007), histological grade 3 (HR 2.0, 95% CI 1.47-2.75; P < 0.001), and metastases of pelvic and para-aortic lymph nodes (PLN and PALN) (HR 2.75, 95% CI 1.13-6.72; P < 0.001) were independent risk factors for PFS. FIGO stage, >1/2 myometrial invasion (HR 1.89, 95% CI 1.34-2.64; P < 0.001), and histological grade 3 (HR 2.42, 95% CI 1.75-3.35; P < 0.001) influenced OS. Complete dissection of PLN and PALN (HR 0.27, 95% CI 0.16-0.45; P < 0.001, and HR 0.14, 95% CI 0.08-0.26; P < 0.001) and the following paclitaxel-based therapy (HR 0.61, 95% CI 0.79-0.92; P = 0.017, and HR 0.48; 95% CI 0.31-0.75; P = 0.001) provided the better PFS and OS, respectively. In management of women with FIGO III-V E-EC, combination of complete staging surgery (complete dissection of PLN and PALN is included) and the following paclitaxel-based therapy could provide the better chance to survive. Patients with tumor >1/2 myometrial invasion and histological grade 3 are risky for disease-related mortality.

1 October 2015 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
HLHei-Yu Lau
Hei-Yu Lau
MCMin-Yu Chen
Min-Yu Chen
YKYu-Min Ke
Yu-Min Ke
JCJen-Ruei Chen
Jen-Ruei Chen
ICI-hui Chen
I-hui Chen
KWKung-Liahng Wang
Kung-Liahng Wang
The goal of this study was to investigate the impact of ovarian preservation on the survival of women with early-stage endometrial cancer, particularly young women. A study cohort of 64 patients with histologically confirmed early-stage endometrial cancer was retrospectively collected from 10 member hospitals of the Taiwanese Gynecologic Oncology Group between 1998 and 2009. Survivorship and overall survival were compared between these two groups using a log-rank test. All patients who underwent surgery were adult women with a mean age of 40.4 ± 9.2 years (range 24-63 years). Ovary-preserving surgery was performed in 38 (59.4%) patients who desired to preserve their ovaries, incidentally in 19 (29.7%) patients with a preoperative diagnosis other than endometrial carcinoma, and in seven patients (10.9%) with unknown reasons. The 5-year recurrence-free survival rate was 98.3% with a median follow up of 44.6 months (range 1.0-126.9 months). Eight patients required adjuvant treatment (12.5%); one patient had documented local recurrence (1.6%); and no metachronous ovarian malignancy occurred during follow up. Preservation of bilateral ovaries does not increase cancer-related mortality. A more conservative approach to surgical staging may be considered in premenopausal women with early-stage endometrial cancer without risk factors.

10 December 2018 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
CLChia-Yi Lee
Chia-Yi Lee
ICI-hui Chen
I-hui Chen
PTPao-Ling Torng
Pao-Ling Torng
Objective: To evaluate surgical outcomes and feasibility of robotic myomectomy in large uterine myomas. Materials and methods This is a retrospective study for robotic myomectomies performed from October 2012 to August 2017 by a single surgeon in a tertiary care referral hospital. Demographics, diagnosis, perioperative variables, operative outcomes and complications were recorded. Large uterine myoma was defined as the estimated diameter of dominant myoma equal to or larger than 10 cm by sonography. Results: Seventy-four patients were included and 32 (43.2%) patients had large uterine myoma. Patients with myoma larger than 10 cm showed significantly heavier myoma weight (446.5 ± 206.2 mg vs. 288.1 ± 147.5, p < 0.001), similar blood loss (309.4 ± 190.3 mL vs. 200.9 ± 285.9 mL, p = 0.06), and longer operative time (263.4 ± 83.7 min vs. 219.1 ± 75.7 min, p = 0.02) compared with patients with myoma <10 cm. The largest myoma removed was 20 cm in diameter. Perioperative complications were rare. Conclusion: Robotic myomectomy is feasible for managing large uterine myomas. It is a safe procedure with acceptable longer operative time.

ICI-hui Chen
I-hui Chen
PTPao-Ling Torng
Pao-Ling Torng
CLChiaYi Lee
ChiaYi Lee
KLKuang-Han Lee
Kuang-Han Lee
HHHeng-Cheng Hsu
Heng-Cheng Hsu
WCWen-fang Cheng
Wen-fang Cheng
Peritoneal tuberculosis (PTB) is an uncommon extrapulmonary infection mimickng primary peritoneal cancer (PPC). We retrospectively included 23 women with PTB and 47 women with PPC treated in a medical center to study the clinical and radiological features that differentiate PTB from PPC. Body temperature above 38 °C was a unique feature of PTB (34.7% versus 0%, p < 0.001). Body Mass Index (BMI) was lower (21.9 ± 3.7 versus 25.2 ± 4.1, p = 0.003), white blood cell (WBC) count was lower (5179.6 ± 1502.2 versus 7716.2 ± 2741.8, p < 0.001), and CA-125 level was lower (508.0 ± 266.1 versus 2130.1 ± 2367.2 U/mL, p < 0.001) in PTB compared with PPC. Imaging detected more pulmonary infiltration and consolidation (52.2% versus 6.4%, p < 0.001), and less omental/mesentery changes (52% versus 83%, p < 0.001) in PTB compared with PPC. The operated patients received earlier treatment compared to patients without operation (7.9 ± 5.3 days versus 17.2 ± 11.0 days, p = 0.010). In conclusion, fever above 38 °C, lower BMI, lower WBC count, less elevated CA-125 level, and imaging of less omental involvement were features of PTB differentiated from PPC.

1 November 2013 in Gynecology and Minimally Invasive Therapy
Verified
Journal Article
Closed access
PTPao-Ling Torng
Pao-Ling Torng
KLKuan-Hung Lin
Kuan-Hung Lin
JHJing-Shiang Hwang
Jing-Shiang Hwang
HLHui-Shan Liu
Hui-Shan Liu
ICI-hui Chen
I-hui Chen
SHSu-Cheng Huang
Su-Cheng Huang
ObjectivesTo assess the learning curve and safety of laparoendoscopic single-site (LESS) surgery of gynecological surgeries.Materials and methodsSixty-three women who underwent LESS surgery by a single experienced laparoscopic surgeon from February 2011 to August 2011 were included. Commercialized single-incision laparoscopic surgery homemade ports were used, along with conventional straight instruments. The learning curve has been defined as the additional surgical time with respect to surgical order of LESS surgery, which has been estimated using a smooth function in a linear model with generalized least squares, with some adjustments made due to influencing factors of the operations.ResultsAll women completed LESS surgeries without the need for ancillary ports, except for two laparotomy conversions due to incidental ovarian malignancy. Three women, one with a gastrointestinal stromal tumor, one with laparoscopic myomectomy, and one who had been receiving simultaneous hysteroscopic myomectomy, were excluded. Of the 58 women included, 39 underwent adnexal surgeries and 19 underwent hysterectomies. Complications occurred with one woman who required a blood transfusion during the procedure. Surgical time was longer in bilateral cystectomy compared with unilateral cystectomy and unilateral/bilateral salpingo-oophorectomy (110.6 ± 51.1 minutes vs. 73.0 ± 26.3 minutes and 66.3 ± 26.9 minutes; p < 0.03); and in laparoscopic total/subtotal hysterectomy (LTH/LSH) compared with laparoscopic-assisted vaginal hysterectomy (LAVH) (205.6 ± 23.3 minutes vs. 120.1 ± 28.6 minutes; P < 0.001). The fitted linear model showed that surgical time was longer in cases with larger adnexal mass, more pelvic adhesion, and more blood loss. Surgical time was longer in LTH/LSH compared with LAVH. Surgical order of LESS surgery was not associated with surgical time.ConclusionLESS is a safe and feasible alternative to conventional laparoscopic surgery for adnexal and uterine diseases. A learning curve is not required for LESS surgery for experienced laparoscopic surgeons